Cognition Therapeutics, Inc.CGTXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-34M

-31.7% YoY

Free Cash Flow

$-28M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	0	-0	0	0
Operating Income	-17	-29↓64.3%	-44↓52.3%	-51↓16.5%	-54↓6.4%
Net Income	-10	-12↓16.3%	1↑106.5%	-26↓3506.6%	-34↓31.7%
EBITDA	-6	-11↓79.1%	-21↓97.0%	-26↓20.7%	-34↓32.0%
EPS Diluted	-0.55	-0.73↓32.7%	-0.74↓1.4%	-0.86↓16.2%	-0.85↑1.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	5	55↑954.6%	42↓24.0%	30↓28.0%	25↓16.4%
Total Current Assets	7	59↑754.0%	48↓19.2%	34↓28.2%	30↓13.6%
Total Assets	7	59↑730.7%	50↓14.7%	35↓30.3%	30↓14.0%
Total Current Liabilities	3	8↑142.0%	8↓0.9%	10↑30.5%	11↑9.6%
Total Liabilities	75	8↓89.6%	10↑29.4%	11↑5.0%	11↑7.4%
Total Equity	-68	51↑175.2%	40↓21.5%	24↓39.2%	19↓23.4%
Total Debt	13	0	1	1↓16.2%	1↓34.2%
Net Debt	8	-55↓814.1%	-40↑26.7%	-29↑28.4%	-24↑15.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-3	-4↓5.8%	-19↓410.4%	-16↑13.6%	-28↓77.8%
Capital Expenditure	-0	-0↓170.0%	-0↓533.3%	-0↑14.0%	-0↑97.3%
Free Cash Flow	-3	-4↓6.2%	-19↓411.3%	-16↑13.6%	-28↓76.2%
Stock-Based Comp	0	5↑991.2%	4↓31.1%	4↑21.9%	4↓13.9%
Net Change in Cash	2	50↑2054.5%	-13↓126.6%	-12↑11.5%	-5↑57.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance